Alterity Therapeutics Files 6-K on Substantial Holding Change
Ticker: PRNAF · Form: 6-K · Filed: Jul 7, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jul 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: substantial-holding, filing-update, registration-statement
TL;DR
Alterity Therapeutics (ATHE) filed a 6-K for a substantial holding change; check ownership shifts.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on July 7, 2025, to report a change in substantial holding. This filing is incorporated by reference into several of their existing Registration Statements on Form S-8 and Form F-3. The company, formerly known as Prana Biotechnology Ltd., is a development stage enterprise focused on pharmaceutical preparations.
Why It Matters
This filing indicates a significant shift in ownership for Alterity Therapeutics, which could impact its stock price and strategic direction.
Risk Assessment
Risk Level: medium — Filings related to changes in substantial holdings can signal shifts in investor confidence or strategic maneuvers, warranting closer attention.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Registrant
- Prana Biotechnology Ltd. (company) — Former company name
- July 7, 2025 (date) — Filing date
- Form S-8 (document) — Incorporated by reference into registration statements
- Form F-3 (document) — Incorporated by reference into registration statements
FAQ
What specific change in substantial holding is reported in the 6-K filing?
The filing explicitly states 'Change in substantial holding' as Exhibit 99.1, but the details of the change are not provided within the provided text of the 6-K header.
Which registration statements is this 6-K filing being incorporated into?
This 6-K is being incorporated by reference into Alterity Therapeutics' Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
What is Alterity Therapeutics' principal executive office address?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
When did Alterity Therapeutics change its name from Prana Biotechnology Ltd.?
The company changed its name from Prana Biotechnology Ltd. on January 5, 2001.
What is the SIC code for Alterity Therapeutics Ltd.?
The Standard Industrial Classification (SIC) code for Alterity Therapeutics Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 7, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).